Background and Aims:Vibration-controlled transient elastography(VCTE)is a noninvasive tool that uses liver stiffness measurement(LSM)to assess fibrosis.Since real-life data during everyday clinical practice in the USA...Background and Aims:Vibration-controlled transient elastography(VCTE)is a noninvasive tool that uses liver stiffness measurement(LSM)to assess fibrosis.Since real-life data during everyday clinical practice in the USA are lacking,we describe the patterns of use and diagnostic performance of VCTE in patients at an academic medical center in New York City.Methods:Patients who received VCTE scans were included if liver biopsy was performed within 1 year.Diagnostic performance of VCTE in differentiating dichotomized fibrosis stages was assessed via area under the receiver operating characteristics(AUROC).Fibrosis stage determined from VCTE LSM was compared to liver biopsy.Results:Of 109 patients,49 had nonalcoholic fatty liver disease,16 chronic hepatitis C,15 congestive hepatopathy,and 22 at least two etiologies.AUROC was 0.90 for differentiating cirrhosis(stage 4)with a positive predictive value(PPV)range of 0.28 to 0.45 and negative predictive value range of 0.96 to 0.98.For 31(32%)patients,VCTE fibrosis stage was at least two stages higher than liver biopsy fibrosis stage.Thirteen of thirty-five pa-tients considered to have cirrhosis by VCTE had stage 0 to 2 and 12 stage 3 fibrosis on liver biopsy.Conclusions:VCTE has reasonable diagnostic accuracy and is reliable at ruling out cirrhosis.However,because of its low PPV,caution must be exercised when used to diagnose cirrhosis,as misdiagnosis can lead to unnecessary health care interventions.In routine practice,VTCE is also sometimes performed for disease etiologies for which it has not been robustly validated.展开更多
基金supported by the Scholarly Projects Program at Columbia University Vagelos College of Physicians and Surgeons,which had no role in the design or execution of this study.
文摘Background and Aims:Vibration-controlled transient elastography(VCTE)is a noninvasive tool that uses liver stiffness measurement(LSM)to assess fibrosis.Since real-life data during everyday clinical practice in the USA are lacking,we describe the patterns of use and diagnostic performance of VCTE in patients at an academic medical center in New York City.Methods:Patients who received VCTE scans were included if liver biopsy was performed within 1 year.Diagnostic performance of VCTE in differentiating dichotomized fibrosis stages was assessed via area under the receiver operating characteristics(AUROC).Fibrosis stage determined from VCTE LSM was compared to liver biopsy.Results:Of 109 patients,49 had nonalcoholic fatty liver disease,16 chronic hepatitis C,15 congestive hepatopathy,and 22 at least two etiologies.AUROC was 0.90 for differentiating cirrhosis(stage 4)with a positive predictive value(PPV)range of 0.28 to 0.45 and negative predictive value range of 0.96 to 0.98.For 31(32%)patients,VCTE fibrosis stage was at least two stages higher than liver biopsy fibrosis stage.Thirteen of thirty-five pa-tients considered to have cirrhosis by VCTE had stage 0 to 2 and 12 stage 3 fibrosis on liver biopsy.Conclusions:VCTE has reasonable diagnostic accuracy and is reliable at ruling out cirrhosis.However,because of its low PPV,caution must be exercised when used to diagnose cirrhosis,as misdiagnosis can lead to unnecessary health care interventions.In routine practice,VTCE is also sometimes performed for disease etiologies for which it has not been robustly validated.
